Enrolling by invitationObservationalLast updated Aug 10, 2026

Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical Study

Overview

ClinicalTrials.gov ID: NCT07755423
Lead Sponsor: Fudan UniversityOTHER
Brief Summary: The goal of this observational study is to evaluate the efficacy and safety of Stereotactic Body Radiotherapy in the treatment of distant metastatic thyroid cancer.
Study Type: Observational

Status

Study Record Dates

NCT05229575Unknown status

Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients

NCT02313298Unknown status

Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer

NCT03392233Recruiting

Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors

NCT02880319Active, not recruiting

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

NCT01352598Completed

Stereotactic Body Radiotherapy for Prostate Cancer

NCT03000816Completed

A Study of SBRT for OligoMetastatic ESCC